![Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay - Research and Practice in Thrombosis and Haemostasis Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay - Research and Practice in Thrombosis and Haemostasis](https://www.rpthjournal.org/cms/asset/d1b28043-9929-487a-9bc3-e760e18239bc/rth212612-fig-0001-m.jpg)
Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay - Research and Practice in Thrombosis and Haemostasis
![Frontiers | Intricate Regulatory Mechanisms of the Anaphase-Promoting Complex/Cyclosome and Its Role in Chromatin Regulation Frontiers | Intricate Regulatory Mechanisms of the Anaphase-Promoting Complex/Cyclosome and Its Role in Chromatin Regulation](https://www.frontiersin.org/files/Articles/687515/fcell-09-687515-HTML/image_m/fcell-09-687515-g001.jpg)
Frontiers | Intricate Regulatory Mechanisms of the Anaphase-Promoting Complex/Cyclosome and Its Role in Chromatin Regulation
![Paradoxical mitotic exit induced by a small molecule inhibitor of APC/CCdc20 | Nature Chemical Biology Paradoxical mitotic exit induced by a small molecule inhibitor of APC/CCdc20 | Nature Chemical Biology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41589-020-0495-z/MediaObjects/41589_2020_495_Figa_HTML.png)
Paradoxical mitotic exit induced by a small molecule inhibitor of APC/CCdc20 | Nature Chemical Biology
![Cancers | Free Full-Text | Novel Molecular Mechanism of Lenalidomide in Myeloid Malignancies Independent of Deletion of Chromosome 5q Cancers | Free Full-Text | Novel Molecular Mechanism of Lenalidomide in Myeloid Malignancies Independent of Deletion of Chromosome 5q](https://pub.mdpi-res.com/cancers/cancers-13-05084/article_deploy/html/images/cancers-13-05084-g001-550.jpg?1634641716)
Cancers | Free Full-Text | Novel Molecular Mechanism of Lenalidomide in Myeloid Malignancies Independent of Deletion of Chromosome 5q
![Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research](https://www.ahajournals.org/cms/asset/aaeb2292-737e-43af-a29d-9c6d7556154d/circresaha.122.321116.fig09.jpg)
Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research
![Molecular drivers of tumor progression in microsatellite stable APC mutation-negative colorectal cancers | Scientific Reports Molecular drivers of tumor progression in microsatellite stable APC mutation-negative colorectal cancers | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-02806-x/MediaObjects/41598_2021_2806_Fig1_HTML.png)
Molecular drivers of tumor progression in microsatellite stable APC mutation-negative colorectal cancers | Scientific Reports
![Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis | Oncogene Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fonc.2012.486/MediaObjects/41388_2013_Article_BFonc2012486_Fig1_HTML.jpg)
Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis | Oncogene
![Evolving synergistic combinations of targeted immunotherapies to combat cancer | Nature Reviews Cancer Evolving synergistic combinations of targeted immunotherapies to combat cancer | Nature Reviews Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrc3973/MediaObjects/41568_2015_Article_BFnrc3973_Fig1_HTML.jpg)